Published in Arch Surg on September 01, 1996
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res (2008) 3.24
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer (2011) 1.66
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer (2012) 1.19
Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? World J Gastroenterol (2007) 1.14
Intestinal melanoma: A broad spectrum of clinical presentation. Int J Surg Case Rep (2012) 1.10
Surgery for distant melanoma metastasis. Cancer J (2012) 1.03
Anal melanoma. Clin Colon Rectal Surg (2006) 1.00
Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literature. World J Surg Oncol (2007) 1.00
Jejuno-jejunal invagination due to intestinal melanoma. World J Gastroenterol (2007) 0.99
Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. PLoS One (2013) 0.97
Primary colonic melanoma presenting as ileocecal intussusception: case report and literature review. World J Gastroenterol (2014) 0.95
Metastatic melanoma of the gallbladder: report of two cases and a review of the literature. Clin Exp Med (2015) 0.92
Morphologically and immunohistochemically undifferentiated gastric neoplasia in a patient with multiple metastatic malignant melanomas: a case report. J Med Case Rep (2008) 0.86
Surgery and sentinel lymph node biopsy. Semin Oncol (2007) 0.85
A patient presenting with acute abdomen due to metastatic small bowel melanoma: a case report. J Med Case Rep (2013) 0.81
Primary small bowel melanoma. A case report and a review of the literature. G Chir (2015) 0.81
Melanoma of the gallbladder: appropriate surgical management and review of the literature. Clin Case Rep (2014) 0.79
"Unsteady gait": an uncommon presentation and course of malignant melanoma in terminal ileum-a case report and review of literature. Case Rep Gastrointest Med (2013) 0.77
Early solitary small bowel metastasis from stage I cutaneous melanoma. Am J Case Rep (2013) 0.77
Gastric metastasis from sphenoid sinus melanoma: A case report. Oncol Lett (2014) 0.76
Intestinal obstruction due to primary intestinal melanoma in a patient with a history of rectal cancer resectioning: A case report. Mol Clin Oncol (2013) 0.76
The skin: a mirror to the gut. Int J Colorectal Dis (2013) 0.76
Bleeding per rectum in a patient with an amputated finger. Saudi J Gastroenterol (2009) 0.75
Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera. J Surg Oncol (2009) 0.75
Primary small bowel melanomas: fact or myth? Ann Transl Med (2016) 0.75
Variant on Manifestation of Duodenal Metastasis 26 Years after Initial Diagnosis of Primary Cutaneous Melanoma. Case Rep Gastroenterol (2010) 0.75
Capsule endoscopy for management of small bowel melanoma-is it time yet? Gastroenterol Hepatol (N Y) (2012) 0.75
Small Bowel Melanoma Metastasing to Inguinal Lymph Node - a Rare Case. Indian J Surg Oncol (2015) 0.75
Solitary metachronous splenic metastasis from cutaneous melanoma. BMJ Case Rep (2012) 0.75
Melanoma Metastasizing to the Small Intestine: A Case Report Illustrating Symptomatic and Asymptomatic Involvement. Cureus (2016) 0.75
Solitary metastatic gallbladder malignant melanoma originated from the nasal cavity: A case report. Int J Surg Case Rep (2013) 0.75
Melanoma with gastric metastases. J Community Hosp Intern Med Perspect (2016) 0.75
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg (1995) 4.37
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol (1989) 2.86
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol (1988) 2.32
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Complications of BCG immunotherapy in patients with cancer. N Engl J Med (1973) 1.72
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol (1998) 1.71
Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am (1999) 1.70
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66
Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences? Ann Surg Oncol (2000) 1.64
Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol (1999) 1.63
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med (1989) 1.62
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma? Ann Surg Oncol (2000) 1.59
Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science (1968) 1.58
Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques. Cancer Res (1975) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol (2001) 1.57
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg (1992) 1.50
Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol (2001) 1.48
Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol (1999) 1.47
Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg (1980) 1.46
Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? Ann Surg Oncol (2000) 1.43
Current management of malignant melanoma. Ann Surg (1990) 1.43
Hepatic resection of metastatic colorectal carcinoma: a ten-year experience. Arch Surg (1982) 1.43
Human liposarcomas: tissue cultures containing foci of transformed cells with viral particles. Science (1969) 1.42
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma. Ann Surg Oncol (2001) 1.42
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy. Ann Thorac Surg (1991) 1.40
Retroperitoneal sarcomas: a reappraisal of treatment. J Surg Oncol (1981) 1.40
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
Granulomatous hepatitis: a complication of B.C.G. immunotherapy. Lancet (1973) 1.38
Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival. Ann Surg Oncol (1999) 1.38
Will the true sentinel node please stand? Ann Surg Oncol (1999) 1.35
Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res (1997) 1.35
Neurofibrosarcoma. Cancer (1980) 1.33
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am (1999) 1.30
Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst (1981) 1.30
Characterization of a minus end-directed kinesin-like motor protein from cultured mammalian cells. J Cell Biol (1995) 1.30
Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer (1984) 1.28
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27
Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res (1974) 1.27
Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27
Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27
Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol (1999) 1.27
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes. Cancer Res (1990) 1.25
Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst (1974) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22
Pulmonary resection for metastatic sarcoma. Am J Surg (1980) 1.22
Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer (2001) 1.19
A membrane antigen common to human cancer and fetal brain tissues. Cancer Res (1976) 1.19
Metastasectomy for recurrent stage IV melanoma. J Surg Oncol (1999) 1.18
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg (2000) 1.18
Immunologic abnormalities in head and neck cancer. Am J Surg (1974) 1.17
Gangliosides of human melanoma. J Natl Cancer Inst (1987) 1.17
Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg (1981) 1.16
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg (1982) 1.15
The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer (2000) 1.15
Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells. Science (1974) 1.15
A review of the literature for whole-body FDG PET in the management of patients with melanoma. Q J Nucl Med (2000) 1.14
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg (2001) 1.14
Lack of correlation between skin reactivity to dinitrochlorobenzene and croton oil in patients with cancer. N Engl J Med (1975) 1.14
Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg (1971) 1.14
Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene (2009) 1.14
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res (1999) 1.14
Immunologic and virus studies with human sarcomas. Surgery (1969) 1.13
Nodal nevi and cutaneous melanomas. Am J Surg Pathol (1996) 1.13
Natural history of surgically treated mucosal melanoma. Am J Surg (1987) 1.13
Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg (1995) 1.13
Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res (1998) 1.12
Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer (1984) 1.12